DB2313 tetrahydrochloride
Based on 7 publication(s) in Google Scholar
DB2313 tetrahydrochloride is a potent transcription factor PU.1 inhibitor with an apoptosis of 14 nM. DB2313 tetrahydrochloride disrupts the interaction of PU.1 with target gene promoters. DB2313 tetrahydrochloride induces apoptosis of acute myeloid leukemia (AML) cells, and has anticancer effects.
For research use only. We do not sell to patients.
- CAS No.: 2170606-75-2
- Formula: C42H45Cl4FN8O2
- Molecular Weight:854.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) DB2313 tetrahydrochloride
More- Ann Rheum Dis. 2024 Aug 20:ard-2024-226067. [Abstract]
- Nat Commun. 2026 Feb 24;17(1):3123. [Abstract]
- Nat Commun. 2025 Aug 4;16(1):7134. [Abstract]
- Adv Sci (Weinh). 2025 Jun;12(21):e2415205. [Abstract]
- Chem Biol Interact. 2024 Dec 1:404:111262. [Abstract]
- J Craniofac Surg. 2026 Mar 2. [Abstract]
- McGill University. 2026.
-
RT-PCR
-
ELISA
-
Flow Cytometry
-
Flow Cytometry
-
Histological Imaging/Staining
Biological Activity
Chemical Information
-
CAS No. 2170606-75-2
-
Molecular Weight 854.67
-
Formula C42H45Cl4FN8O2
-
SMILES
FC1=C(COC2=CC=C(C3=NC4=CC=C(C(NC(C)C)=N)C=C4N3)C=C2)C=CC=C1COC5=CC=C(C6=NC7=CC=C(C(NC(C)C)=N)C=C7N6)C=C5.Cl.Cl.Cl.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (7)
-
Journal Impact Factor
-
Most Recent
-
Ann Rheum Dis
2024 Aug 20:ard-2024-226067. PMID: 39164066
DB2313 tetrahydrochloride purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2024 Aug 20:ard-2024-226067. [Abstract]
DB2313 (0.3 mg; i.p.; once every 3 d) downregulated IL-9 expression and the proportions of Th9 cells in the spleen and PBMCs of collagen-induced arthritis (CIA) mice.
DB2313 tetrahydrochloride purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2024 Aug 20:ard-2024-226067. [Abstract]
PU.1 inhibitor DB2313 (0.3 mg; i.p.; once every 3 d) suppressed IL-9 release from Th9 cells of collagen-induced arthritis (CIA) mice.
DB2313 tetrahydrochloride purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2024 Aug 20:ard-2024-226067. [Abstract]
Effect of PU.1 inhibitor DB2313 (0.3 mg; i.p.; once every 3 d) on joint neovascularization in collagen-induced arthritis (CIA) mice.
-
Nat Commun
DNA-PK-mediated phosphorylation of STAT6 establishes a non-canonical type 2 immunity axis to prevent macrophage senescence. [Abstract]2026 Feb 24;17(1):3123. PMID: 41735318 -
Nat Commun
Unveiling genetic signatures of immune response in immune-related diseases through single-cell eQTL analysis across diverse conditions. [Abstract]2025 Aug 4;16(1):7134. PMID: 40759647
DB2313 tetrahydrochloride purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Aug 4;16(1):7134. [Abstract]
DB2313 (660 nM) inhibited the transcription of CSF1R, CALM1, and SLC2A3 while promoting E2F in neutrophils.
DB2313 tetrahydrochloride purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Aug 4;16(1):7134. [Abstract]
DB2313 (17 mg/kg; i.p.) decreased serum levels of MMP9 and MPO/DNA‐NETs in the murine MI/RI model.
-
Adv Sci (Weinh)
MMP9High Neutrophils are Critical Mediators of Neutrophil Extracellular Traps Formation and Myocardial Ischemia/Reperfusion Injury. [Abstract]2025 Jun;12(21):e2415205. PMID: 40151877 -
Chem Biol Interact
4-Hydroxybenzoic acid restrains Nlrp3 inflammasome priming and activation via disrupting PU.1 DNA binding activity and direct antioxidation. [Abstract]2024 Dec 1:404:111262. PMID: 39389441 -
J Craniofac Surg
PU.1 Inhibition Attenuates Neuroinflammation and Pyroptosis After Traumatic Brain Injury by Modulating Microglial Polarization. [Abstract]2026 Mar 2. PMID: 41769894 -
Purity & Documentation
References
[1]. Iléana Antony-Debré, et al. Pharmacological inhibition of the transcription factor PU.1 in leukemia. J Clin Invest. 2017 Dec 1;127(12):4297-4313. [Content Brief]
[2]. Zhang S, Zhao S, Qi Y, et al. SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner. Mol Ther Nucleic Acids. 2022;27:699-717. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)